Recent advances in diagnosis and treatment for malignancies of the gastrointestinal tract

Digestion

Volumn 85, Issue 2, 2012, Pages 95-98

  Watanabe, Masayuki ^a   Baba, Hideo ^a   Ishioka, Chikashi ^b   Nishimura, Yasumasa ^c   Muto, Manabu ^d  

^a KUMAMOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Gastrointestinal cancer; Less invasive treatment; Multimodal treatment

Indexed keywords

CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ADVANCED CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; CONFERENCE PAPER; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG RESPONSE; EARLY CANCER; EARLY DIAGNOSIS; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; GASTRECTOMY; GLASGOW OUTCOME SCALE; HUMAN; MINIMALLY INVASIVE PROCEDURE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; PERITONEUM METASTASIS; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TRANSLATIONAL RESEARCH;

COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; ESOPHAGEAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; HUMANS;

EID: 84856202881     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000334677     Document Type: Conference Paper

References (10)

1. Watanabe M, Nagai Y, Kinoshita K, Saito S, Kurashige J, Karashima R, Hirashima K, Sato N, Imamura Y, Hiyoshi Y, Baba Y, Iwagami S, Miyamoto Y, Iwatsuki M, Hayashi N, Baba H: Induction chemotherapy with docetaxel/cisplatin/ 5-fluorouracil for patients with node-positive esophageal cancer. Digestion 2011; 83: 146-152.
2. Oda I, Gotoda T, Hamanaka H, Eguchi T, Saito Y, Matsuda T, Bhandari P, Emura F, Saito D, Ono H: Endoscopic submucosal dissection for early gastric cancer: technical feasibility, operation time and complications from a large consecutive series. Dig Endosc 2005; 17: 54-58. (Pubitemid 40313081)
3. Songun I, Putter H, Kranenbarg EMK, Sasako M, van Velde CJH: Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial.Lancet Oncol 2010; 11: 439-449.
4. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG: Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT- 0089. J Clin Oncol 2003; 21: 2912-2919. (Pubitemid 46621841)
5. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, Hiratsuka M, Tsujinaka T, Kinoshita T, Arai K, Yamamura Y, Okajima K, for the Japan Clinical Oncology Group: D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462.
6. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Kloppel G, Dhaene K, Michelassi F, and the Lymphadenectomy Study Group: Standard versus extended lymphadenectomy associated with pancreatoduodenectomyin the surgical treatment of adenocarcinoma of the head of the pancreas. A multicenter, prospective, randomized study. Ann Oncol 1998; 228: 508-517. (Pubitemid 30194394)
7. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H,Higashino M, Yamamura Y, Kurita A, Arai K, for the ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820. (Pubitemid 350044801)
8. Andre T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, Bonetti A, Clingan P, Bridgewater J, Rivera F, de Gramont A. Improved overall survival with oxaliplatin, fluorouracil and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-3116.
9. Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomized phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009; 101: 908-915.
10. Igaki H, Kato H, Ando N, Shimada M, Shimizu H Nakamura T, Ozawa S, Yabusaki H, Aoyama N, Kurita A, Fukuda H: A randomized trial of postoperative chemotherapy with cisplatin and 5-fluorouracil versus neoadjuvant chemotherapy for clinical stage II/ III squamous cell carcinoma of the thoracic esophagus (abstract). ASCO Annual Meeting, 2008.